4//SEC Filing
Subramony Siddarth 4
Accession 0000950170-24-067363
CIK 0001863127other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:30 PM ET
Size
6.2 KB
Accession
0000950170-24-067363
Insider Transaction Report
Form 4
Subramony Siddarth
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-29+18,600→ 18,600 totalExercise: $15.94Exp: 2034-05-28→ Common Stock (18,600 underlying)
Footnotes (2)
- [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 29, 2024, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
- [F2]These securities are owned directly by the Reporting Person, who may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC, (iv) Joseph C. Lewis, (v) Aaron Davis and (vi) the Reporting Person (collectively, the "Boxer Group"). Each member of the Boxer Group other than the Reporting Person disclaims beneficial ownership of these securities to the extent it does not have a pecuniary interest therein
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880624
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:30 PM ET
- Size
- 6.2 KB